Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

BDRX Relative to the S&P 500

BDRX Relative to the Sector

Seasonal Chart Analysis

Analysis of the Biodexa Pharmaceuticals Plc (NASD:BDRX) seasonal charts above shows that a Buy Date of June 7 and a Sell Date of August 31 has resulted in a geometric average return of 10.47% above the benchmark rate of the S&P 500 Total Return Index over the past 8 years. This seasonal timeframe has shown positive results compared to the benchmark in 5 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 8 years by an average of 110.47% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 8 years of data is available for shares of BDRX, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

To download BDRX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: BDRX